Limits...
VWA domain of S5a restricts the ability to bind ubiquitin and Ubl to the 26S proteasome.

Piterman R, Braunstein I, Isakov E, Ziv T, Navon A, Cohen S, Stanhill A - Mol. Biol. Cell (2014)

Bottom Line: We identify the VWA domain of S5a as a domain that limits ubiquitin and Ubl binding to occur only upon proteasomal association.Multiubiquitination events within the VWA domain can further regulate S5a association.Our results provide a molecular explanation to how ubiquitin and Ubl binding to S5a is restricted to the 26S proteasome.

View Article: PubMed Central - PubMed

Affiliation: Department of Biochemistry, Rappaport Family Institute for Research in the Medical Sciences, Technion-Israel Institute of Technology, Haifa 31096, Israel.

Show MeSH

Related in: MedlinePlus

S5a–UBL interaction. (A) Immunoblot of hPlic and the proteasomal subunits PSMA1, S5a, and PSMD14 in fractions of glycerol gradients prepared from WT cells. Proteasomal chymotrypsin activity along the gradient is indicated below. (B) Lysates from control and S5a kd cells were subjected to PSMA1 (26S) IP, followed by PSMD14, S5a, and hPlic immunoblots. Asterisk indicates a nonspecific band. (C) Lysates from control and S5a kd cells treated with Velcade were subjected to PSMA1 (26S) IP, followed by incubation with the T7.UBL.Sic1 substrate. Unbound material was extensively washed, and matrix content was found with regard to Sic1 (T7), S5a, and proteasomal content (PSMD14). (D) The degradation of T7.UBL.Sic1 was performed by using 26S proteasomes acquired from control and S5a kd cells. At the indicated time points, samples were extracted and content analyzed by the various immunoblots. Note the disappearance of T7.UBL.Sic1 upon proteasomal incubation and the stability upon Velcade treatment. Quantification of T7 signal is indicated (right), and UBL.Sic1 stability in the absence of proteasomes is shown.
© Copyright Policy - creative-commons
Related In: Results  -  Collection


getmorefigures.php?uid=PMC4263443&req=5

Figure 3: S5a–UBL interaction. (A) Immunoblot of hPlic and the proteasomal subunits PSMA1, S5a, and PSMD14 in fractions of glycerol gradients prepared from WT cells. Proteasomal chymotrypsin activity along the gradient is indicated below. (B) Lysates from control and S5a kd cells were subjected to PSMA1 (26S) IP, followed by PSMD14, S5a, and hPlic immunoblots. Asterisk indicates a nonspecific band. (C) Lysates from control and S5a kd cells treated with Velcade were subjected to PSMA1 (26S) IP, followed by incubation with the T7.UBL.Sic1 substrate. Unbound material was extensively washed, and matrix content was found with regard to Sic1 (T7), S5a, and proteasomal content (PSMD14). (D) The degradation of T7.UBL.Sic1 was performed by using 26S proteasomes acquired from control and S5a kd cells. At the indicated time points, samples were extracted and content analyzed by the various immunoblots. Note the disappearance of T7.UBL.Sic1 upon proteasomal incubation and the stability upon Velcade treatment. Quantification of T7 signal is indicated (right), and UBL.Sic1 stability in the absence of proteasomes is shown.

Mentions: To further evaluate the role of S5a as a proteasomal Ubl recruitment factor, we affinity purified 26S proteasomes from control and S5a kd cells and evaluated them for the Ubl-dependent shuttling factor hPlic-2 (UBQLN2; the mammalian homologue of yeast Dsk2; Kleijnen et al., 2000). As noted in Figure 3A, most hPlic is not associated with higher–molecular weight (HMW) proteasomal fractions, consistent with its role as a proteasome shuttle factor (Kleijnen et al., 2003). To evaluate the dependence of hPlic on S5a proteasomal recruitment, proteasomes purified from control and S5a kd cells were evaluated for their hPlic content. A significant reduction in hPlic content was observed in the S5a kd cells (Figure 3B), implying a central role for S5a in Ubl proteasomal recruitment. To extend this evaluation to additional Ubl's, we used the ability of fusion proteins with a Ubl domain to enable proteasomal degradation (Kraut and Matouschek, 2011). We fused a Ubl domain from RAD23 to Sic1 and monitored the ability of the Ubl domain to enable proteasomal binding and degradation. On incubation of the Ubl-Sic1 substrate with proteasomes purified from control and S5a kd cells, we noted reduced binding of the substrate to the S5a kd proteasomes (Figure 3C). The outcome of the reduced proteasomal binding of Ubl in the S5a kd cells is reflected in an in vitro degradation assay in which the attenuated degradation rates of the Ubl substrate are observed in the S5a kd cells (Figure 3D).


VWA domain of S5a restricts the ability to bind ubiquitin and Ubl to the 26S proteasome.

Piterman R, Braunstein I, Isakov E, Ziv T, Navon A, Cohen S, Stanhill A - Mol. Biol. Cell (2014)

S5a–UBL interaction. (A) Immunoblot of hPlic and the proteasomal subunits PSMA1, S5a, and PSMD14 in fractions of glycerol gradients prepared from WT cells. Proteasomal chymotrypsin activity along the gradient is indicated below. (B) Lysates from control and S5a kd cells were subjected to PSMA1 (26S) IP, followed by PSMD14, S5a, and hPlic immunoblots. Asterisk indicates a nonspecific band. (C) Lysates from control and S5a kd cells treated with Velcade were subjected to PSMA1 (26S) IP, followed by incubation with the T7.UBL.Sic1 substrate. Unbound material was extensively washed, and matrix content was found with regard to Sic1 (T7), S5a, and proteasomal content (PSMD14). (D) The degradation of T7.UBL.Sic1 was performed by using 26S proteasomes acquired from control and S5a kd cells. At the indicated time points, samples were extracted and content analyzed by the various immunoblots. Note the disappearance of T7.UBL.Sic1 upon proteasomal incubation and the stability upon Velcade treatment. Quantification of T7 signal is indicated (right), and UBL.Sic1 stability in the absence of proteasomes is shown.
© Copyright Policy - creative-commons
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC4263443&req=5

Figure 3: S5a–UBL interaction. (A) Immunoblot of hPlic and the proteasomal subunits PSMA1, S5a, and PSMD14 in fractions of glycerol gradients prepared from WT cells. Proteasomal chymotrypsin activity along the gradient is indicated below. (B) Lysates from control and S5a kd cells were subjected to PSMA1 (26S) IP, followed by PSMD14, S5a, and hPlic immunoblots. Asterisk indicates a nonspecific band. (C) Lysates from control and S5a kd cells treated with Velcade were subjected to PSMA1 (26S) IP, followed by incubation with the T7.UBL.Sic1 substrate. Unbound material was extensively washed, and matrix content was found with regard to Sic1 (T7), S5a, and proteasomal content (PSMD14). (D) The degradation of T7.UBL.Sic1 was performed by using 26S proteasomes acquired from control and S5a kd cells. At the indicated time points, samples were extracted and content analyzed by the various immunoblots. Note the disappearance of T7.UBL.Sic1 upon proteasomal incubation and the stability upon Velcade treatment. Quantification of T7 signal is indicated (right), and UBL.Sic1 stability in the absence of proteasomes is shown.
Mentions: To further evaluate the role of S5a as a proteasomal Ubl recruitment factor, we affinity purified 26S proteasomes from control and S5a kd cells and evaluated them for the Ubl-dependent shuttling factor hPlic-2 (UBQLN2; the mammalian homologue of yeast Dsk2; Kleijnen et al., 2000). As noted in Figure 3A, most hPlic is not associated with higher–molecular weight (HMW) proteasomal fractions, consistent with its role as a proteasome shuttle factor (Kleijnen et al., 2003). To evaluate the dependence of hPlic on S5a proteasomal recruitment, proteasomes purified from control and S5a kd cells were evaluated for their hPlic content. A significant reduction in hPlic content was observed in the S5a kd cells (Figure 3B), implying a central role for S5a in Ubl proteasomal recruitment. To extend this evaluation to additional Ubl's, we used the ability of fusion proteins with a Ubl domain to enable proteasomal degradation (Kraut and Matouschek, 2011). We fused a Ubl domain from RAD23 to Sic1 and monitored the ability of the Ubl domain to enable proteasomal binding and degradation. On incubation of the Ubl-Sic1 substrate with proteasomes purified from control and S5a kd cells, we noted reduced binding of the substrate to the S5a kd proteasomes (Figure 3C). The outcome of the reduced proteasomal binding of Ubl in the S5a kd cells is reflected in an in vitro degradation assay in which the attenuated degradation rates of the Ubl substrate are observed in the S5a kd cells (Figure 3D).

Bottom Line: We identify the VWA domain of S5a as a domain that limits ubiquitin and Ubl binding to occur only upon proteasomal association.Multiubiquitination events within the VWA domain can further regulate S5a association.Our results provide a molecular explanation to how ubiquitin and Ubl binding to S5a is restricted to the 26S proteasome.

View Article: PubMed Central - PubMed

Affiliation: Department of Biochemistry, Rappaport Family Institute for Research in the Medical Sciences, Technion-Israel Institute of Technology, Haifa 31096, Israel.

Show MeSH
Related in: MedlinePlus